Hostname: page-component-8448b6f56d-wq2xx Total loading time: 0 Render date: 2024-04-19T11:35:56.273Z Has data issue: false hasContentIssue false
  • English
  • Français

Assessment of Time to Clinical Response in Patients with Sepsis Treated Before and After Implementation of a Matrix-Assisted Laser Desorption Ionization Time-of-Flight Blood Culture Identification Algorithm

Published online by Cambridge University Press:  09 June 2016

Joseph J. Carreno ,
Ben M. Lomaestro ,
Apryl L. Jacobs ,
Rachel E. Meyer ,
Ann Evans  and
Clemente I. Montero
Joseph J. Carreno*
Affiliation:
Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York
Ben M. Lomaestro
Affiliation:
Department of Pharmacy, Albany Medical Center Hospital Albany, New York
Apryl L. Jacobs
Affiliation:
Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York
Rachel E. Meyer
Affiliation:
Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York
Ann Evans
Affiliation:
Department of Microbiology, Albany Medical Center Hospital, Albany, New York
Clemente I. Montero
Affiliation:
Department of Microbiology, Albany Medical Center Hospital, Albany, New York
*
Address correspondence to Joseph J. Carreno, PharmD, Albany College of Pharmacy and Health Sciences, School of Pharmacy and Pharmaceutical Sciences, Department of Pharmacy Practice, Albany, NY, 12208 (Joseph.Carreno@acphs.edu).
Get access Rights & Permissions [Opens in a new window]

Abstract

OBJECTIVE

To evaluate time to clinical response before and after implementation of rapid blood culture identification technologies.

DESIGN

Before-and-after trial.

SETTING

Large, tertiary, urban, academic health-sciences center.

PATIENTS

Patients >18 years old with sepsis and concurrent bacteremia or fungemia were included in the study; patients who were pregnant, had polymicrobial septicemia, or were transferred from an outside hospital were excluded.

INTERVENTION

Prior to the intervention, polymerase chain reaction was used to identify Staphylococcus species from positive blood cultures, and traditional laboratory techniques were used to identify non-staphylococcal species. After the intervention, matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) assay and FilmArray were also used to identify additional species. During both periods, the antimicrobial stewardship team provided prospective audit and feedback for all patients on antibiotics.

RESULTS

A total of 219 patients were enrolled in the study: 115 patients prior to the intervention and 104 after the intervention. The median time to clinical response was statistically significantly shorter in the postintervention group than in the preintervention group (2 days vs 4 days, respectively; P=.002). By Cox regression, the implementation of MALDI-TOF and FilmArray was associated with shorter time to clinical response (hazard ratio [HR], 1.360; 95% confidence interval [CI], 1.018–1.816). After controlling for potential confounders, the study group was not independently associated with clinical response (adjusted HR, 1.279; 95% CI, 0.955–1.713). Mortality was numerically, but not statistically significantly, lower in the postintervention group than in the preintervention group (7.6% vs 11.4%; P=.342).

CONCLUSIONS

In the setting of an existing antimicrobial stewardship program, implementation of MALDI-TOF and FilmArray was associated with improved time to clinical response. Further research is needed to fully describe the effect of antimicrobial stewardship programs on time to clinical response.

Infect Control Hosp Epidemiol 2016;37:916–923

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 37 , Issue 8 , August 2016 , pp. 916 - 923
Copyright
© 2016 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION. These data were presented in part in Abstract K-659 at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy in Washington, District of Columbia, on September 7, 2014.

References

REFERENCES

1. Mayr, FB, Yende, S, Angus, DC. Epidemiology of severe sepsis. Virulence 2014;5:4–11.CrossRefGoogle ScholarPubMed
2. Hall, MJ, Williams, SN, DeFrances, CJ, Golosinskiy, A. Inpatient care for septicemia or sepsis: a challenge for patients and hospitals. NCHS Data Brief 2011:1–8.Google ScholarPubMed
3. McPherson, D, Griffiths, C, Williams, M, et al. Sepsis-associated mortality in England: an analysis of multiple cause of death data from 2001 to 2010. BMJ Open 2013;3.CrossRefGoogle ScholarPubMed
4. Kaukonen, KM, Bailey, M, Suzuki, S, Pilcher, D, Bellomo, R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA 2014;311:1308–1316.CrossRefGoogle ScholarPubMed
5. Dellinger, RP, Levy, MM, Rhodes, A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013;39:165–228.CrossRefGoogle ScholarPubMed
6. Kumar, A, Roberts, D, Wood, KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589–1596.CrossRefGoogle ScholarPubMed
7. Dellit, TH, Owens, RC, McGowan, JE Jr., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159–177.CrossRefGoogle Scholar
8. Bauer, KA, Perez, KK, Forrest, GN, Goff, DA. Review of rapid diagnostic tests used by antimicrobial stewardship programs. Clin Infect Dis 2014;59(Suppl 3):S134–S145.CrossRefGoogle ScholarPubMed
9. Bauer, KA, West, JE, Balada-Llasat, JM, Pancholi, P, Stevenson, KB, Goff, DA. An antimicrobial stewardship program’s impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis 2010;51:1074–1080.CrossRefGoogle ScholarPubMed
10. Wong, JR, Bauer, KA, Mangino, JE, Goff, DA. Antimicrobial stewardship pharmacist interventions for coagulase-negative staphylococci positive blood cultures using rapid polymerase chain reaction. Annals Pharmacotherapy 2012;46:1484–1490.CrossRefGoogle ScholarPubMed
11. Huang, AM, Newton, D, Kunapuli, A, et al. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis 2013;57:1237–1245.CrossRefGoogle ScholarPubMed
12. Nagel, JL, Huang, AM, Kunapuli, A, et al. Impact of antimicrobial stewardship intervention on coagulase-negative Staphylococcus blood cultures in conjunction with rapid diagnostic testing. J Clin Microbiol 2014;52:2849–2854.CrossRefGoogle ScholarPubMed
13. Perez, KK, Olsen, RJ, Musick, WL, et al. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. J Infect 2014;69:216–225.CrossRefGoogle ScholarPubMed
14. Powers, JH. Increasing the efficiency of clinical trials of antimicrobials: the scientific basis of substantial evidence of effectiveness of drugs. Clin Infect Dis 2007;45(Suppl 2):S153–S162.CrossRefGoogle ScholarPubMed
15. Lodise, TP, Anzueto, AR, Weber, DJ, et al. Assessment of time to clinical response, a proxy for discharge readiness, among hospitalized patients with community-acquired pneumonia who received either ceftaroline fosamil or ceftriaxone in two phase III FOCUS trials. Antimicrob Agent Chemother 2015;59:1119–1126.CrossRefGoogle ScholarPubMed
16. Stellrecht, KA, Grifasi, ML, Graffunder, EM, Lodise, TP. Impact of rapid PCR blood culture testing for Staphylococcus aureus and MRSA on patient care. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy; 2009; Chicago, IL.Google Scholar
17. Antimicrobial Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Developing Drugs for Treatment. Food and Drug Administration website. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM234907.pdf. Published 2010. Accessed August 25, 2011.Google Scholar
18. Guidance for Industry. Community-Acquired Bacterial Pneumonia: Developing Drugs for Treatment, Draft Guidance. Food and Drug Administration website. http://www.fda.gov.elibrary.amc.edu/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm123686.pdf. Published 2009. Accessed August 8, 2014.Google Scholar
19. Frye, AM, Baker, CA, Rustvold, DL, et al. Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia. J Clin Microbiol 2012;50:127–133.CrossRefGoogle ScholarPubMed
20. Terp, S, Krishnadasan, A, Bowen, W, et al. Introduction of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing and antibiotic selection among hospitalized patients with purulent skin infections. Clin Infect Dis 2014;58:e129–e132.CrossRefGoogle ScholarPubMed
21. Ly, T, Gulia, J, Pyrgos, V, Waga, M, Shoham, S. Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time. Ther Clin Risk Manag 2008;4:637–640.Google ScholarPubMed
22. Holtzman, C, Whitney, D, Barlam, T, Miller, NS. Assessment of impact of peptide nucleic acid fluorescence in situ hybridization for rapid identification of coagulase-negative staphylococci in the absence of antimicrobial stewardship intervention. J Clin Microbiol 2011;49:1581–1582.CrossRefGoogle ScholarPubMed
23. Johannsson, B, Beekmann, SE, Srinivasan, A, Hersh, AL, Laxminarayan, R, Polgreen, PM. Improving antimicrobial stewardship: the evolution of programmatic strategies and barriers. Infect Control Hosp Epidemiol 2011;32:367–374.CrossRefGoogle ScholarPubMed
24. Harris, AD, Bradham, DD, Baumgarten, M, Zuckerman, IH, Fink, JC, Perencevich, EN. The use and interpretation of quasi-experimental studies in infectious diseases. Clin Infect Dis 2004;38:1586–1591.Google ScholarPubMed
25. Young, JQ, Ranji, SR, Wachter, RM, Lee, CM, Niehaus, B, Auerbach, AD. “July effect”: impact of the academic year-end changeover on patient outcomes: a systematic review. Annals Internal Med 2011;155:309–315.CrossRefGoogle ScholarPubMed
26. Shardell, M, Harris, AD, El-Kamary, SS, Furuno, JP, Miller, RR, Perencevich, EN. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin Infect Dis 2007;45:901–907.Google Scholar
27. Zasowski, E, Butterfield, JM, McNutt, LA, et al. Relationship between time to clinical response and outcomes among Pneumonia Outcomes Research Team (PORT) risk class III and IV hospitalized patients with community-acquired pneumonia who received ceftriaxone and azithromycin. Antimicrob Agent Chemother 2014;58:3804–3813.CrossRefGoogle ScholarPubMed
28. Halm, EA, Fine, MJ, Marrie, TJ, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA 1998;279:1452–1457.CrossRefGoogle ScholarPubMed
29. Aliberti, S, Peyrani, P, Filardo, G, et al. Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia. Chest 2011;140:482–488.CrossRefGoogle ScholarPubMed